New compounds, compositions and methods for treatment of inflammatory diseases and conditions

Details for Australian Patent Application No. 2003255851 (hide)

International Classifications

Event Publications

6 November 2003 Complete Application Filed

Priority application(s): 60/394,670 08.07.02 US

11 March 2004 Application Open to Public Inspection

Published as AU-B-2003255851

1 February 2007 Change of Name(s) of Applicant(s), Section 104

Pilva-Istrazivacki Institut d.o.o. The name of the applicant has been changed to GlaxoSmithKline istrazivacki centar Zagreb d.o.o.

23 July 2009 Application Accepted

Published as AU-B-2003255851

19 November 2009 Standard Patent Sealed

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.